synergism sequenced combinations curcumin epigallocatechin num gallate cisplatin killing human ovarian cancer cells pubmed ncbi abstract drug resistance remains on-going challenge ovarian cancer chemotherapy objective study determine effect synergism activity sequenced combinations cisplatin cis curcumin cur epigallocatechin num gallate egcg human ovarian cancer cell lines drugs added binary combinations cis combined cur cis combined egcg human ovarian num num cisr cancer cell lines sequences administration num num num num num combination index ci assess combined action drugs cis num num synergism additiveness antagonism cellular accumulation platinum platinum-dna binding levels cis combination phytochemicals determined graphite furnace atomic absorption spectrometry addition cis num cur egcg num combination produced synergistic outcomes num num cisr cell lines cellular accumulations platinum platinum-dna binding resulting num combinations greater compared values cis providing explanation synergistic action sequenced combinations cis cur egcg applied human ovarian num num cisr cancer cell lines lower concentrations shorter time gap additions produce higher cytotoxic effect 
